Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer by Fabrice Barlesi, Adrien Dixmier, Didier Debieuvre, Christophe Raspaud, Jean-Bernard Auliac, Nicolas Benoit, Pierre Bombaron, Denis Moro-Sibilot, Bernard Asselain, Clarisse Audigier-Valette, Florence Brellier, François-Emery Cotté, Yaacoub Khalife, Maurice Pérol

Get full text